This is read by an automated voice. Please report any issues or inconsistencies here. Dr. Stacy Norton was only 7 years old when her mother, one of several family members struck by aggressive tumors ...

The two sides aim to pursue joint investment, research, scientific publications, and the development of advanced biomedical products, leveraging the strengths of both research institutes and the two ...

Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.

Spider-Man Brand New Day science earns expert review from a Cambridge biochemist who confirms the film named siRNA correctly ...

A domestic research team is developing an anticancer technology that attacks DNA mutations found only in cancer cells while ...

Scientists at the Center for Molecular Medicine Cologne (CMMC) and the CECAD Cluster of Excellence on Aging Research have demonstrated in a biomedical study that ribosomes, the protein factories of ...

Flusiva is the first FDA-approved seasonal influenza vaccine to use mRNA technology. Beyond influenza itself, how significant is this approval for the future development of vaccines and infectious ...

New research led by the Hudson Institute of Medical Research has shown how a cell recognizes that it is infected with a virus to protect itself and surrounding cells or induce inflammation. The ...

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

Meghan McCain demanded Dr. Fauci be "put in jail" due to the contents of text messages about the COVID-19 vaccine and ...

Texts obtained from Dr. Anthony Fauci’s phone include a chat between Biden administration officials about pregnant women ...

The vaccine, called mFLUSIVA, is expected to be a versatile new option for people seeking protection from influenza and an important step forward for the widespread adoption of mRNA technology.